...

Copeptin and Nonalcoholic Fatty Liver Disease

Determine if copeptin levels, a marker of vasopressin, correlates with presence and severity of fatty liver disease.


Why this Research Matters

See above


Who can Participate

Adult

Obese 30-40 BMI, age 30-75 Diabetes, other liver disease or eGFR<45.


Study ID

Protocol Number: 17-1160
More information available at ClinicalTrials.gov: NCT03254563

Meet the Team

Image of Principal Investigator

Thomas Jensen, MD

Principal Investigator